Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Basotherm was a German pharmaceutical company focused on dermatological and related pharmaceutical preparations. Historical sources describe it as a pharmaceutical unit of Boehringer Ingelheim that was acquired by Galderma Deutschland in 1997, adding multiple dermatology products to Galderma's German business. Corporate registry records indicate Basotherm GmbH was later merged into Galderma Laboratorium GmbH in August 2013 and terminated as a separate legal entity. Patent records also suggest Basotherm conducted ophthalmology-related development work, including topical formulations intended to lower increased intraocular pressure. Overall, Basotherm appears to have been a specialty pharma business centered on dermatology, with limited evidence of a broader standalone pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Basotherm.